Reference Library

FAQ

The answers below are intentionally blunt because ambiguity is expensive in this market.

Use this page for
Clarifying what belongs in a real due-diligence process before a provider narrative gets to define the frame for you.

Short answers to the right questions.

Q

Does a high readiness score mean the treatment will work?

No. It means the offer is documented enough to evaluate responsibly. Biology still refuses guarantees.

Q

Is paying before documentation ever reasonable?

A small scheduling deposit can be normal. Full payment or a large deposit before you have the COA, procedure plan, and safety protocol is a documented fraud pattern.

Q

Can testimonials count as evidence?

They can count as stories. They cannot establish causation without baseline, follow-up, and controls.

Q

Are treatments abroad always suspect?

No. They are simply harder to verify and harder to recover from when something goes wrong.

Q

Why does the framework care so much about manufacturer identity?

Because unnamed products cannot be audited for evidence, safety controls, release criteria, or chain of custody.

Q

Can a physician's confidence substitute for trial data?

No. Confidence can coexist with poor documentation, mismatched route logic, and sales pressure.